Policy makers should vet the methodology behind reported cost savings before trusting the numbers, says Halima ...
EHR-based case finding identified 21.5% of coded PV patients with hematocrit above the <45% target, enabling intervention ...
ORMS, which arises in the orbit or eyelid, accounts for about 10% of childhood rhabdomyosarcoma (RMS) cases. As the orbit's tight anatomy makes complete surgical resection difficult without ...
Marc A. Sala, MD, discusses bronchiectasis awareness gaps, care strategies, and the importance of cross-specialty ...
Scheduling-linked alerts provide “just-in-time” trial options ahead of visits, enabling earlier identification and ...
Jubril Oyeyemi, MD, FHELA, serves as the chief medical officer of Camden Coalition of Health Care Providers, the medical ...
The FDA has approved oveporexton (Orzeyful), the first orexin agonist for narcolepsy type 1, based on phase 3 data showing ...
More prediabetes screening, earlier GLP-1/SGLT2 inhibitor use, and broader CGM access in type 2 diabetes are needed, says ...
Drugs that form the backbone of CLL therapy are also used across lymphoma subtypes, explains Adam S. Kittai, MD. The ...
Marc A. Sala, MD, explains why long COVID overlaps with respiratory disease and how multidisciplinary care improves diagnosis ...
Here are 5 things stakeholders should know about the debate over establishing legitimate peptide regulations. Kennedy ...
In "Monitoring Disease Progression and Liver Cancer Risk in Hepatitis B," our experts turn to how chronic hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results